Centessa Pharmaceuticals, a wholly owned subsidiary of Eli Lilly and Company, is a clinical-stage company developing orexin receptor 2 (OX2R) agonists for narcolepsy and potentially other sleep-wake disorders. Its lead investigational candidate, cleminorexton, is being developed for narcolepsy type 1, narcolepsy type 2, and idiopathic hypersomnia. The Senior Advisor, Clinical Science will serve as a scientific partner to study teams and the medical monitor, primarily supporting Phase 2–3 clinical trials for Orexin-targeted programs in sleep/wake indications. Performing at the Associate Director level, this role brings clinical and scientific expertise to day-to-day study conduct and interpretation. The role helps ensure studies align with protocols, internal processes, GCP/ICH and regulatory requirements, and broader clinical development strategy. Work spans protocol development, study startup, trial execution, recruitment, study and data monitoring, and closeout data analysis. The position partners across Clinical Operations, Translational Science, Regulatory Affairs, Biostatistics, and Safety/Pharmacovigilance, and reports to the Executive Director, Clinical Development. This is a US-based remote role with occasional travel. The anticipated wage is $153,000–$283,800. Full-time equivalent employees are eligible for a company bonus, depending in part on company and individual performance. Eligible employees may participate in a comprehensive benefits program that includes a company-sponsored 401(k), pension, vacation benefits, medical, dental, vision and prescription drug benefits, flexible benefits, life insurance and death benefits, time-off and leave benefits, and well-being benefits.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior